Glucotrack (GCTK) EBITDA Margin (2014 - 2020)
Glucotrack's (GCTK) quarterly EBITDA Margin came in at 629896.91% in Q2 2020, down 62908771.0% YoY from N/an in Q3 2019, and down 1711.37% on a QoQ basis from 34774.61% in Q1 2020.
Glucotrack (GCTK) EBITDA Margin (2014 - 2020) Analysis & Trends
Glucotrack (GCTK) has 7 years of EBITDA Margin data on file, last reported at 629896.91% in Q2 2020.
- Quarterly EBITDA Margin fell 62908771.0% year-over-year to 629896.91% in Q2 2020, while the trailing twelve-month figure through Sep 2020 was 5929.83% (up 725681.0% YoY) and the FY2019 annual result came in at 1685.58%, up 1672099.0% from the prior year.
- EBITDA Margin eased to 629896.91% in Q2 2020, from 34774.61% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 9455.8% in Q4 2019 to a low of 629896.91% in Q2 2020.
- A 5-year average of 45883.65% and a median of 1219.42% in 2016 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2018 — EBITDA Margin surged 1715389 bps — and 2020, when it tumbled 62908771 bps.
- Tracing GCTK's EBITDA Margin over 5 years: stood at 1020.51% in 2016, then soared by 490 bps to 3984.61% in 2017, then sank by 430 bps to 13130.81% in 2018, then soared by 172 bps to 9455.8% in 2019, then tumbled by 6761 bps to 629896.91% in 2020.
- The last three EBITDA Margin figures came in at 629896.91% (Q2 2020), 34774.61% (Q1 2020), and 9455.8% (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 33.60% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 13.31% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 0.39% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 30.66% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 5.14% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 20.53% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 8.19% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -2.87% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 7.33% |
| 10 | Glucotrack | 1.73 Mn | 607,139.82 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -629,896.91% |
| Mar 31, 2020 | -34,774.61% |
| Dec 31, 2019 | 9,455.80% |
| Sep 30, 2019 | -23,484.38% |
| Jun 30, 2019 | -809.19% |
| Mar 31, 2019 | 4,010.07% |
| Jun 30, 2018 | -13,130.81% |
| Mar 31, 2018 | 6,770.21% |
| Dec 31, 2017 | 3,984.61% |
| Sep 30, 2017 | -12,671.59% |
| Jun 30, 2017 | -30,284.70% |
| Mar 31, 2017 | 2,701.25% |
| Dec 31, 2016 | -1,020.51% |
| Sep 30, 2016 | -13,154.55% |
| Jun 30, 2016 | -414.80% |
| Mar 31, 2016 | -1,418.33% |
| Jun 30, 2015 | -1,627.81% |
| Mar 31, 2015 | -1,161.49% |
| Dec 31, 2014 | -3,102.19% |
| Sep 30, 2014 | -3,041.82% |